29 08, 2023 A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants Neal Evan Caminsky2023-08-29T11:51:33-04:00August 29, 2023|Funded Research Results, Pillar 10|
21 08, 2023 Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals Neal Evan Caminsky2023-08-23T14:40:13-04:00August 21, 2023|Funded Research Results, Pillar 2|
21 08, 2023 Clinical and serological predictors of Post COVID-19 Condition: Findings from a Canadian prospective cohort study Neal Evan Caminsky2023-08-23T14:41:36-04:00August 21, 2023|Funded Research Results, Pillar 9|
21 08, 2023 The metallodrug BOLD-100 is a potent inhibitor of SARS-CoV-2 replication and has broad-acting antiviral activity Neal Evan Caminsky2023-08-21T09:32:06-04:00August 21, 2023|Funded Research Results, Pillar 3|
8 08, 2023 Detection of prevalent SARS-CoV-2 variant lineages in wastewater and clinical sequences from cities in Québec, Canada Neal Evan Caminsky2023-08-08T16:17:10-04:00August 8, 2023|Funded Research Results, Pillar 6|
3 08, 2023 Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection Neal Evan Caminsky2023-08-03T14:57:57-04:00August 3, 2023|Funded Research Results, Pillar 1|
31 07, 2023 Prevalence of Low-Frequency, Antiviral Resistance Variants in SARS-CoV-2 Isolates in Ontario, Canada, 2020-23 Neal Evan Caminsky2023-07-31T16:28:22-04:00July 31, 2023|Funded Research Results, Pillar 10|
21 07, 2023 Cohort profile: Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination Neal Evan Caminsky2023-07-21T16:45:59-04:00July 21, 2023|Funded Research Results, CoVaRR-Net Biobank|
17 07, 2023 Synthetic Analogs of the Sponge Sesterterpenoid Alotaketal C are Potent Inhibitors of SARS-CoV-2 Omicron BA.1 and BA.5 Infections of Human Lung Cells Neal Evan Caminsky2023-07-19T13:13:08-04:00July 17, 2023|Funded Research Results, Pillar 10|
27 06, 2023 Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens Neal Evan Caminsky2023-06-27T11:46:21-04:00June 27, 2023|Funded Research Results, Pillar 3|
